Drugs / RO7673396
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06884618 | Apr 2025 → Aug 2028 expected | neoplasm | Hoffmann-La Roche | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7673396 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06884618 ↗ |